These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2834576)

  • 21. [Infection defense antigens against pathogenic viruses to human. Infection defense antigens and genetic code--trend and progress of study on biomolecular analysis. c. Infection defense antigens of poliovirus].
    Nomoto A
    Nihon Rinsho; 1987 Oct; 45(10):2239-44. PubMed ID: 2452260
    [No Abstract]   [Full Text] [Related]  

  • 22. Progress made towards the development of a CMV peptide vaccine.
    Paston SJ; Dodi IA; Madrigal JA
    Hum Immunol; 2004 May; 65(5):544-9. PubMed ID: 15172455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mechanisms in evasion of host immune response by HCMV].
    Satoh T; Arase H
    Nihon Rinsho; 2006 Mar; 64 Suppl 3():421-6. PubMed ID: 16615508
    [No Abstract]   [Full Text] [Related]  

  • 24. Human antibody response to human cytomegalovirus-specific DNA-binding proteins.
    Gergely L; Czeglédy J; Váczi L
    Acta Virol; 1988 Jan; 32(1):1-5. PubMed ID: 2897767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytomegalovirus infection as a complication of blood transfusion.
    Tegtmeier GE
    Semin Liver Dis; 1986 Feb; 6(1):82-95. PubMed ID: 3012785
    [No Abstract]   [Full Text] [Related]  

  • 26. Immune response to human cytomegalovirus infection.
    Rasmussen L
    Curr Top Microbiol Immunol; 1990; 154():221-54. PubMed ID: 2161322
    [No Abstract]   [Full Text] [Related]  

  • 27. QuantiFERON®-CMV assay for the assessment of cytomegalovirus cell-mediated immunity.
    Giulieri S; Manuel O
    Expert Rev Mol Diagn; 2011 Jan; 11(1):17-25. PubMed ID: 21171917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Infection defense antigens against pathogenic viruses to human. Infection defense antigens and genetic code--trend and progress of study on biomolecular analysis. b. Herpes simplex virus].
    Kenichi U
    Nihon Rinsho; 1987 Oct; 45(10):2235-8. PubMed ID: 2834573
    [No Abstract]   [Full Text] [Related]  

  • 29. UL40-mediated NK evasion during productive infection with human cytomegalovirus.
    Wang EC; McSharry B; Retiere C; Tomasec P; Williams S; Borysiewicz LK; Braud VM; Wilkinson GW
    Proc Natl Acad Sci U S A; 2002 May; 99(11):7570-5. PubMed ID: 12032324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiviral immunity and T-regulatory cell function are retained after selective alloreactive T-cell depletion in both the HLA-identical and HLA-mismatched settings.
    Davies JK; Koh MB; Lowdell MW
    Biol Blood Marrow Transplant; 2004 Apr; 10(4):259-68. PubMed ID: 15077224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Infection defense antigens against pathogenic viruses to human. Infection defense antigens and genetic code--trend and progress of study on biomolecular analysis. f. Varicella-zoster virus].
    Yamanishi K
    Nihon Rinsho; 1987 Oct; 45(10):2258-62. PubMed ID: 2834574
    [No Abstract]   [Full Text] [Related]  

  • 32. Cytomegalovirus (CMV) IE1- and pp65-specific CD8+ T cell responses broaden over time after primary CMV infection in infants.
    Gibson L; Dooley S; Trzmielina S; Somasundaran M; Fisher D; Revello MG; Luzuriaga K
    J Infect Dis; 2007 Jun; 195(12):1789-98. PubMed ID: 17492595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Inclusion bodies of human cytomegalovirus are composed of the DNA and immediately early and early antigens of the virus].
    Yan QG; Huang GS; Guo Y; Wang Z; Feng JL; Yang GR
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):262-5. PubMed ID: 15340573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of proteins encoded by IE regions 1 and 2 of human cytomegalovirus using monoclonal antibodies generated against recombinant antigens.
    Plachter B; Britt W; Vornhagen R; Stamminger T; Jahn G
    Virology; 1993 Apr; 193(2):642-52. PubMed ID: 7681609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Human cytomegalovirus infection: new methods for virological diagnosis].
    Mazeron MC; Alain-Albertini S
    Pathol Biol (Paris); 1993 May; 41(5):487-94. PubMed ID: 8414683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of a major target of the human immune response to cytomegalovirus using monoclonal antibodies.
    Gold D; Ashley R; Abbo H; Corey L
    J Med Virol; 1988 Jun; 25(2):237-43. PubMed ID: 2839615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IgG antibody against early antigen in subclinical congenital cytomegalovirus infection.
    Chiba S; Kamada M; Hanazono H; Motokawa T; Nakao T; Komori A
    Lancet; 1979 Mar; 1(8114):496. PubMed ID: 85083
    [No Abstract]   [Full Text] [Related]  

  • 38. Significance of herpesvirus immediate early gene expression in cellular immunity to cytomegalovirus infection.
    Reddehase MJ; Koszinowski UH
    Nature; 1984 Nov 22-28; 312(5992):369-71. PubMed ID: 6095095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation and application of a monoclonal antibody raised against a recombinant cytomegalovirus-specific polypeptide.
    Jahn G; Harthus HP; Bröker M; Borisch B; Platzer B; Plachter B
    Klin Wochenschr; 1990 Oct; 68(20):1003-7. PubMed ID: 2178202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of antiphospholipid autoantibody during cytomegalovirus infection.
    Cheng HM; Khairullah NS
    Clin Infect Dis; 1997 Dec; 25(6):1493-4. PubMed ID: 9431416
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.